# FDA 483 - Daniel C. Tarquinio, DO - November 05, 2021

Source: https://www.globalkeysolutions.net/records/483/daniel-c-tarquinio-do/5f0a4a7d-5044-4785-8f81-706a2fa59a82

> FDA 483 for Daniel C. Tarquinio, DO on November 05, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Daniel C. Tarquinio, DO
- Inspection Date: 2021-11-05
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: Daniel Tarquinio, DO, a clinical investigator in Norcross, GA, received an FDA Form 483 citing significant deficiencies during an inspection. The observations included failures to conduct investigations according to the investigational plan, specifically regarding the enrollment of pediatric subjects in concurrent studies and incomplete safety analyses. Additionally, the firm's records for investigational drug disposition were found to be inadequate, lacking proper accountability for dispensed and returned product.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/sereen-g-morgan-murray/1900ad73-5999-471e-8f74-63627bd1aa2a)

Company: https://www.globalkeysolutions.net/companies/daniel-c-tarquinio-do/1030731e-fe69-4ddd-b711-3507df3eeaad

Office: https://www.globalkeysolutions.net/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7